Search

everythinglearnresearchcommunity

for

Search:↓

The best method to monitor dutasteride in rat plasma is liquid-liquid extraction with methyl tert-butyl ether and methylene chloride.

A 645-nm diode laser effectively penetrates swine soft tissues, suggesting predictable therapeutic effects.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

A reliable severity score for female pattern hair loss was developed and validated.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Finger length ratios don't predict baldness in men.

Finasteride and dutasteride both increase chromogranin A levels similarly.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

PRP can help treat hair loss but needs standardized methods for best results.

Dexpanthenol improves hair growth in male baldness.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Androgenetic alopecia is more common in men, often linked to genetics and hormones.

Finasteride for hair loss has minimal impact on sexual function.

Longer finasteride treatment improves male pattern hair loss, with significant results at 12 months.

Finasteride may reduce heart damage in rats.

Reliable method detects finasteride in human plasma at low doses.

Finasteride does not cause sexual dysfunction in men with hair loss.

A new method accurately measures cyclic AMP levels in small skin and hair samples.

Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

PRP treatment significantly increases hair density in men with androgenetic alopecia.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Single-spin PRP may be more effective for hair loss, but more research is needed.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride can cause skin reactions, so dermatologists should be aware.

Titanflow improves male urinary health by strengthening the detrusor muscle and enhancing urine flow.